AngioGenex, Inc.
company.status.inactiveCIK 1085596fmd_0X9BSM97365D8SE3WA5BQ3CFNNManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Jun 30, 2019, 12 periods
| Line item | FY2016 | FY2017 | FY2018 |
|---|---|---|---|
| Net interest income | – | (0) | (0) |
| Research and development | 0 | 0 | 0 |
| Total operating expenses | 0 | 1 | 0 |
| Operating income | (0) | (1) | (0) |
| Interest expense | (0) | (0) | (0) |
| Net income | (0) | (1) | (0) |